to explore results)
- New Horizons in Predictive Drug Metabolism and Pharmacokinetics, CHAPTER 12 Drug–Drug Interactions: Regulatory and Theoretical Considerations, and an Industry Perspective.
, Pages 263-282
- Drug Discovery for Psychiatric Disorders, CHAPTER 14 Pharmacotherapies for Drug Addiction.
, Pages 357-383
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 3 The β-Lactam (Azetidin-2-one) as a Privileged Ring in Medicinal Chemistry.
, Pages 64-97
- Drug Discovery from Natural Products, Chapter 15 Retapamulin: a First-in-Class Pleuromutilin Antibiotic.
, Pages 326-338
- Protein Crystallography: Challenges and Practical Solutions, Chapter 8 Crystallography with X-ray Free Electron Lasers.
, Pages 181-224
- Drug Discovery for Psychiatric Disorders, CHAPTER 10 Glutamate Approaches Towards the Treatment of Mood Disorders.
, Pages 258-275
- Antimicrobial Materials for Biomedical Applications, Chapter 17 Overview of Antimicrobial Resistance and Nanoparticulate Drug Delivery Approach to Combat Antimicrobial Resistance.
, Pages 481-516
- Manganese in Health and Disease, Chapter 10 Mechanism of Manganese-Induced Impairment of Astrocytic Glutamate Transporters.
, Pages 258-278
- Toxicological Effects of Veterinary Medicinal Products in Humans: Volume 1, CHAPTER 8 Antimicrobial Drugs.
, Volume 1
, Pages 273-380
- Pharmaceuticals in the Environment, Distribution of Pharmaceutical Residues in the Environment.
, Pages 34-69